wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52807922-E7C3CF44-0CBC-4574-B723-628FC1E3FE52
Q52807922-E7C3CF44-0CBC-4574-B723-628FC1E3FE52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52807922-E7C3CF44-0CBC-4574-B723-628FC1E3FE52
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
P2860
Q52807922-E7C3CF44-0CBC-4574-B723-628FC1E3FE52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52807922-E7C3CF44-0CBC-4574-B723-628FC1E3FE52
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f481371634d0c570b3c42aa77e552b8474e66437
P2860
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study